Literature DB >> 20847431

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

Robert G Struble1, Tom Ala, Peter R Patrylo, Gregory J Brewer, Xiao-Xin Yan.   

Abstract

The amyloid cascade hypothesis has guided much of the research into Alzheimer's disease (AD) over the last 25 years. We argue that the hypothesis of amyloid-β (Aβ) as the primary cause of dementia may not be fully correct. Rather, we propose that decline in brain metabolic activity, which is tightly linked to synaptic activity, actually underlies both the cognitive decline in AD and the deposition of Aβ. Aβ may further exacerbate metabolic decline and result in a downward spiral of cognitive function, leading to dementia. This novel interpretation can tie the disparate risk factors for dementia to a unifying hypothesis and present a roadmap for interventions to decrease the prevalence of dementia in the elderly population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847431      PMCID: PMC3079347          DOI: 10.3233/JAD-2010-100846

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  59 in total

1.  Odorant deprivation reversibly modulates transsynaptic changes in the NR2B-mediated CREB pathway in mouse piriform cortex.

Authors:  Hyun H Kim; Adam C Puche; Frank L Margolis
Journal:  J Neurosci       Date:  2006-09-13       Impact factor: 6.167

2.  beta-Secretase expression in normal and functionally deprived rat olfactory bulbs: inverse correlation with oxidative metabolic activity.

Authors:  Xiao-Xin Yan; Kun Xiong; Xue-Gang Luo; Robert G Struble; Richard W Clough
Journal:  J Comp Neurol       Date:  2007-03-01       Impact factor: 3.215

3.  Diabetes is related to cerebral infarction but not to AD pathology in older persons.

Authors:  Z Arvanitakis; J A Schneider; R S Wilson; Y Li; S E Arnold; Z Wang; D A Bennett
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

Review 4.  Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.

Authors:  Dennis J Selkoe
Journal:  Behav Brain Res       Date:  2008-02-17       Impact factor: 3.332

Review 5.  Alzheimer disease pathology as a host response.

Authors:  Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

6.  Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.

Authors:  Keiichi Kawasaki; Kenji Ishii; Yoko Saito; Keiichi Oda; Yuichi Kimura; Kiichi Ishiwata
Journal:  Ann Nucl Med       Date:  2008-05-23       Impact factor: 2.668

Review 7.  Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.

Authors:  Hani Atamna; William H Frey
Journal:  Mitochondrion       Date:  2007-06-13       Impact factor: 4.160

8.  Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

Authors:  Clive Holmes; Delphine Boche; David Wilkinson; Ghasem Yadegarfar; Vivienne Hopkins; Anthony Bayer; Roy W Jones; Roger Bullock; Seth Love; James W Neal; Elina Zotova; James A R Nicoll
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

9.  Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina.

Authors:  Kun Xiong; Huaibin Cai; Xue-Gang Luo; Robert G Struble; Richard W Clough; Xiao-Xin Yan
Journal:  Exp Brain Res       Date:  2007-04-12       Impact factor: 1.972

Review 10.  Genetic aspects of Alzheimer disease.

Authors:  Thomas D Bird
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

View more
  32 in total

Review 1.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

2.  BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.

Authors:  Yan Cai; Xue-Mei Zhang; Lauren N Macklin; Huaibin Cai; Xue-Gang Luo; Salvatore Oddo; Frank M Laferla; Robert G Struble; Gregory M Rose; Peter R Patrylo; Xiao-Xin Yan
Journal:  Neurotox Res       Date:  2011-07-02       Impact factor: 3.911

3.  γ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF Aβ.

Authors:  Fei Liu; Zhi-Qin Xue; Si-Hao Deng; Xiong Kun; Xue-Gang Luo; Peter R Patrylo; Gregory M Rose; Huaibin Cai; Robert G Struble; Yan Cai; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2013-02-22       Impact factor: 3.386

4.  Apoptogenic interactions of plasmalemmal type-1 VDAC and Aβ peptides via GxxxG motifs induce Alzheimer's disease - a basic model of apoptosis?

Authors:  Friedrich P Thinnes
Journal:  Wien Med Wochenschr       Date:  2011-04-04

5.  Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury.

Authors:  Jian-Ming Li; Zhi-Qin Xue; Si-Hao Deng; Xue-Gang Luo; Peter R Patrylo; Gregory W Rose; Huaibin Cai; Yan Cai; Xiao-Xin Yan
Journal:  Neurotox Res       Date:  2012-10-05       Impact factor: 3.911

Review 6.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

7.  Bioenergetics breakdown in Alzheimer's disease: targets for new therapies.

Authors:  Uday Saxena
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-06-12

Review 8.  The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.

Authors:  Megan M Varnum; Tsuneya Ikezu
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-06-19       Impact factor: 4.291

Review 9.  Preventing Alzheimer's disease by means of natural selection.

Authors:  Lloyd A Demetrius; Jane A Driver
Journal:  J R Soc Interface       Date:  2015-01-06       Impact factor: 4.118

Review 10.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.